ZYUS Life Sciences Corp. Brief: Says Cannabis Drug License Enables It to Expand Its Clinical Research Activities by Manufacturing Drugs Containing Cannabis in Canada

MT Newswires · Jun 4 21:08

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

ZYUS Life Sciences Corp. Brief: Says Cannabis Drug License Enables It to Expand Its Clinical Research Activities by Manufacturing Drugs Containing Cannabis in Canada

Risk Disclaimer